COMMUNIQUÉ DE PRESSE publié le 18/07/2024 à 19:37, il y a 2 mois 2 jours Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces transaction in own shares, purchasing 158,976 ordinary shares at prices between 108.00p and 112.50p on the London Stock Exchange London Stock Exchange Share Buyback Own Shares Funding Circle Plc Transaction
BRÈVE publiée le 17/07/2024 à 18:22, il y a 2 mois 3 jours Funding Circle Plc: POS-Transaction in Own Shares Share Buy-back Stock Exchange Transaction Numis Securities Funding Circle
BRÈVE publiée le 17/07/2024 à 18:22, il y a 2 mois 3 jours Funding Circle Plc : Transaction POS en actions propres Rachat D'actions Bourse Transaction Numis Securities Cercle De Financement
COMMUNIQUÉ DE PRESSE publié le 17/07/2024 à 18:17, il y a 2 mois 3 jours Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces the purchase and cancellation of ordinary shares as part of its buy-back program on the London Stock Exchange. Details of the transactions disclosed London Stock Exchange Share Buyback Programme Own Shares Funding Circle Plc POS-Transaction
BRÈVE publiée le 16/07/2024 à 18:17, il y a 2 mois 4 jours Funding Circle Plc : Transaction POS en actions propres Rachat D'actions Actions Ordinaires Numis Securities Bourse De Londres Cercle De Financement
BRÈVE publiée le 16/07/2024 à 18:17, il y a 2 mois 4 jours Funding Circle Plc: POS-Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Numis Securities Funding Circle
COMMUNIQUÉ DE PRESSE publié le 16/07/2024 à 18:12, il y a 2 mois 4 jours Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc purchased 290,396 of its ordinary shares for cancellation as part of its buy-back program. Share capital will consist of 345,743,513 shares post-cancellation Share Buy-back London Stock Exchange Ordinary Shares Funding Circle Plc Share Cancellation
BRÈVE publiée le 15/07/2024 à 18:06, il y a 2 mois 5 jours Funding Circle Plc : Transaction POS en actions propres Rachat D'actions Actions Ordinaires Numis Securities Bourse De Londres Cercle De Financement
BRÈVE publiée le 15/07/2024 à 18:06, il y a 2 mois 5 jours Funding Circle Plc: POS-Transaction in Own Shares Share Buy-back London Stock Exchange Ordinary Shares Numis Securities Funding Circle
COMMUNIQUÉ DE PRESSE publié le 15/07/2024 à 18:01, il y a 2 mois 5 jours Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces the purchase and cancellation of 200,000 ordinary shares on the London Stock Exchange in a buy-back program, with detailed transaction information provided London Stock Exchange Ordinary Shares Cancellation Funding Circle Plc Buy-back
Publié le 20/09/2024 à 17:40, il y a 13 heures 47 minutes Availability of the 2024 Half-Year Financial Report
Publié le 20/09/2024 à 17:40, il y a 13 heures 47 minutes Mise à disposition du Rapport Financier Semestriel 2024
Publié le 20/09/2024 à 23:40, il y a 7 heures 47 minutes Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Publié le 20/09/2024 à 23:30, il y a 7 heures 57 minutes Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Publié le 20/09/2024 à 23:00, il y a 8 heures 27 minutes AI/ML Innovations Inc. Provides Second Status Update
Publié le 20/09/2024 à 22:30, il y a 8 heures 57 minutes Electric Metals Announces Changes to its Board of Directors
Publié le 20/09/2024 à 22:15, il y a 9 heures 12 minutes Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Publié le 20/09/2024 à 22:58, il y a 8 heures 29 minutes Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Publié le 20/09/2024 à 21:00, il y a 10 heures 27 minutes Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Publié le 20/09/2024 à 20:14, il y a 11 heures 13 minutes EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Publié le 20/09/2024 à 19:50, il y a 11 heures 37 minutes BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Publié le 20/09/2024 à 19:47, il y a 11 heures 40 minutes EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma